Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT02683200
What this trial is testing

MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaMetastatic Malignant Neoplasm in the Liver
Jonsson Comprehensive Cancer Center 21
Early research (Phase 1)Active Not RecruitingNCT01366144
What this trial is testing

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Breast CarcinomaCarcinoma of Unknown PrimaryEndometrial Carcinoma+11 more
National Cancer Institute (NCI) 94
Not applicableStudy completedNCT02447237
What this trial is testing

Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients

Who this might be right for
Hematological DiseaseDelayed Gastric EmptyingMalignant Disease
Jens Rikardt Andersen 20
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT02638051
What this trial is testing

Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT

Who this might be right for
Peritoneal NeoplasmsAscitesYang Deficiency+1 more
Galenic Research Institute Ltd 260
Not applicableLooking for participantsNCT06364553
What this trial is testing

Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study

Who this might be right for
Oesophageal Cancer
Erasmus Medical Center 30
Early research (Phase 1)Ended earlyNCT04099277
What this trial is testing

LY3435151 in Participants With Solid Tumors

Who this might be right for
Solid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more
Eli Lilly and Company 2
Not applicableStudy completedNCT04593277
What this trial is testing

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8+13 more
Fred Hutchinson Cancer Center 549
Not applicableLooking for participantsNCT07291414
What this trial is testing

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Who this might be right for
Breast CarcinomaColorectal CarcinomaLung Carcinoma+2 more
University of Michigan Rogel Cancer Center 80
Not applicableStudy completedNCT06197984
What this trial is testing

Antimicrobial Resistance in Acute Cholangitis

Who this might be right for
Cholangitis AcuteBiliary Tract DiseasesJaundice; Malignant+2 more
Emergency County Hospital Pius Brinzeu; Timisoara, Romania 1,435
Not applicableStudy completedNCT02337673
What this trial is testing

Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography

Who this might be right for
Pulmonary DiseasePostoperative Respiratory ComplicationsMalignant Neoplasm of Stomach+2 more
Johannes Gutenberg University Mainz 130
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableActive Not RecruitingNCT04275557
What this trial is testing

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Who this might be right for
Pancreatic CancerPancreatic Cyst
H. Lee Moffitt Cancer Center and Research Institute 1,274
Not applicableNot Yet RecruitingNCT06375954
What this trial is testing

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Who this might be right for
Malignant Biliary ObstructionPancreatic CancerBiliary Tract Neoplasms
Hospital Universitari de Bellvitge 96
Early research (Phase 1)Active Not RecruitingNCT05103631
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Who this might be right for
Liver Cell CarcinomaSolid TumorWilms Tumor+5 more
Baylor College of Medicine 12
Large-scale testing (Phase 3)UnknownNCT02363049
What this trial is testing

Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer

Who this might be right for
Malignant Neoplasm of Large IntestineColon Cancer Liver Metastasis
Assistance Publique - Hôpitaux de Paris 278
Not applicableStudy completedNCT03259763
What this trial is testing

EUS-GE vs ES for Palliation of Gastric Outlet Obstruction

Who this might be right for
Gastric Outlet Obstruction
Johns Hopkins University 112
Early research (Phase 1)Study completedNCT00892736
What this trial is testing

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Who this might be right for
Basal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more
National Cancer Institute (NCI) 98
Testing effectiveness (Phase 2)Study completedNCT00112463
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01046487
What this trial is testing

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

Who this might be right for
Cancer
Centre Oscar Lambret 26
Next Page